Global Peptic Ulcer Drugs Market 2016 to 2022 – Market Share, Growth, Statistics, Competitor Landscape, Key Players Analysis, Trends and Forecasts

“Global Peptic Ulcer Drugs Market”
Global Peptic Ulcer Drugs Market Information, by Pharmacological class (proton pump inhibitors (PPIs) by Forecast to 2022

Market Highlights:

Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show average growth at a CAGR of 3.8 % from 2016 to 2022.

The major driving factors for Petic Ulcers Drug Market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco analcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics.

Request a Sample Report @

Major Key Players:

  • Novartis AG, Daiichi Sankyo Company Limited
  • Acetelion Ltd
  • Boehringer Ingelheim
  • Sanofi S.A
  • Astra Zeneca plc
  • Ranbaxy Laboratories Limited, Inc
  • Takeda Pharmaceuticals Company Limited
  • Pfizer Inc. Helicure AB


Global peptic ulcer drugs market has been segmented on the basis of pharmacological class which comprises proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others along with this the market is also segmented by clinical applications into gastric ulcers, duodenal ulcer and esophageal ulcer. 

Regional Analysis:

Depending on geographic region, Peptic Ulcer drug market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for peptic ulcer drugs. Europe is the second largest market of  peptic ulcer drugs. The developed region will lose the lead to the developing in the near future.

Intended Audience:

  • Global peptic ulcer drugs manufacturers
  • Global peptic ulcer drugs suppliers
  • Research and development Laboratories
  • Market research and consulting service providers

Access Report Details @

Table of Contents

  1   Introduction

  1.1 Definition

  1.2 Scope of Study

  1.3 Research Objective

  1.4 Assumptions & Limitations

  1.5 Market Structure

  2   Research Methodology

  2.1 Research Process

  2.2 Primary Research

  2.3 Secondary Research


List of Tables

Table 1 Global Peptic Ulcer Drugs Market, 2013-2022 (Usd Million)

Table 2 Global Peptic Ulcer Drugs Market, 2013-2022 (Usd Million)


List of Figures

Figure 1 Research Process

Figure 2 Porters Five Forces Model


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India